Cell Lysis Market

Cells contain biomolecules such as proteins or nucleic acids present in the cytoplasm and enclosed within a membrane. Cell lysis is a process in which a cell membrane is ruptured due to some external forces or conditions such as viral infection or osmosis, resulting in the release of cell contents, thus in subsequent death of the cell. In industries and research laboratories, cell lysis is often used to break open the cell to study its internal components. The two methods through which cell lysis can be achieved include mechanical and chemical methods. Mechanical cell lysis method includes high shear mixing, sonication, freeze or thaw cycles, traditional homogenization, grinding, and high pressure homogenization whereas, chemical lysis method comprises osmotic lysis, and the use of detergents, chelating agents.

Market Dynamics

The global cell lysis market is projected to witness significant growth over the forecast period, owing to increasing prevalence of chronic diseases and increasing development in cell lysis by key market players. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015 data findings, 5,251 deaths were reported due to influenza infection in 2015, in the U.S. Furthermore, according to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024. Such increasing prevalence of cancer and infectious disease are expected to drive growth of the cell lysis market. Moreover, increasing research and development expenditure by biopharmaceutical industries and biotechnology industries fosters growth of the cell lysis market. According to 2012 EU Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sector represented 17.7% of business R&D expenditure globally. However, high cost of cell based research, owing to high expenditure in research and development for CAR-T cell therapy hampers growth of the cell lysis market.

Key features of the study:

• This report provides in-depth analysis of the cell lysis market, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global cell lysis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
• Key companies covered as a part of this study include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Thermo Fisher Scientific, Qiagen N.V., Qsonica, Merck KGaA, and F. Hoffman-La Roche Ltd..
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
• The global cell lysis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for cell lysis products, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:

• Global Cell Lysis Market, By Product Type:
• Instruments
• Consumables
• Global Cell Lysis Market, By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• Global Cell Lysis Market, By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Global Cell Lysis Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• By Product Type:
• Instruments
• Consumables
• By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Product Type:
• Instruments
• Consumables
• By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Product Type:
• Instruments
• Consumables
• By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• By Product Type:
• Instruments
• Consumables
• By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• By Product Type:
• Instruments
• Consumables
• By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Africa
• By Country:
• South Africa
• North Africa
• Central Africa
• By Product Type:
• Instruments
• Consumables
• By Cell Type:
• Mammalian Cells
• Microbial Cells
• Other Cells
• By End User:
• Academic and Research Labs
• Pharmaceutical and Biotechnology Companies
• Company Profiles
• Becton, Dickinson and Company*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Qiagen N.V.
• Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.
• Cell Signalling Technology, Inc.
• Qsonica

 “*” marked represents similar segmentation in other categories in the respective section.